Skip to main content
. 2020 Oct 15;10(4):386–391.

Table 1.

Summary of the case report

Case description A 32-year-old woman with cardiac valve disease and spherocytosis, diagnosed with COVID-19. Systemic microvascular reactivity assessed with cutaneous laser doppler perfusion monitoring, with thermal hyperemia
First microcirculation test Performed in the worst day of clinical evolution-severely impaired microvascular vasodilation, compared to a healthy control
Second microcirculation test Performed after clinical and laboratory improvement-marked increase in baseline microvascular flow and endothelial-dependent vasodilation